<DOC>
	<DOCNO>NCT01642121</DOCNO>
	<brief_summary>This laboratory study look biomarkers sample young patient acute myeloid leukemia . Studying sample bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer</brief_summary>
	<brief_title>Studying Biomarkers Samples From Younger Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>Study Subtype : Observational Observational Study Model : Case-control Time Perspective : Retrospective Biospecimen Retention : Samples With DNA Biospecimen Description : Cryopreserved bone marrow sample Study Population Description : Patient sample AML1-ETO translocation cytologically normal AML sample control Sampling Method : Non-Probability Sample OBJECTIVES : I . To address whether mutation-specific cell-surface marker observe murine system allow prospective isolation leukemia stem cell ( LSC ) human bone marrow sample cytogenetic abnormality . II . To compare incidence leukemia NSG mouse receive CD34+CD38 marker+ cell NSG mice receive hypothesize normal cell ( CD34+CD38 marker-subset ) patient . OUTLINE : Samples control sort re-sorted CD34 , CD38 , CD55 subsets single-cell polymerase chain reaction ( PCR ) analysis , flow cytometry , reverse-transcriptase PCR . Sorted cell subset transplant NSG mouse . Beginning 6 week transplantation , peripheral blood sample collect analyzed human lymphoid- myeloid-lineage cell fluorescence-activated cell sort ( FACS ) .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Leukemia , Monocytic , Acute</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Acute</mesh_term>
	<criteria>Frozen bone marrow aspirate obtain childhood acute myeloid leukemia ( AML ) patient possess define cytogenetic mutation ; AML1ETO inv ( 16 ) Samples cytogenetically normal AML case obtain University Alabama Birmingham ( UAB ) control</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>